WORX Stock Slides As Nasdaq Reinstatement Trade Kicks Off

SCWorx Corp. faces heightened downside risk as dilution fears from new stock offerings weigh on shares, already trading down -19.62 percent.

Live Update At 08:32:09 EDT: On Tuesday, October 13, 2026 SCWorx Corp. stock [NASDAQ: WORX] is trending down by -19.62%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

WORX is trading like a tiny, volatile biotech, even though it sits in health‑care data. The daily chart shows SCWorx spiking from the low $3s to a $7.25 high on 2026/10/06, then fading hard into the mid‑$3s and now $3.16. That’s a classic blow‑off move followed by profit‑taking and panic selling.

Intraday, the 5‑minute premarket tape on WORX shows a slide from around $6 near 04:55 down under $3 by 06:40, then grinding in the mid‑$2s. That tells traders liquidity is there, but the dominant side right now is selling. For day traders, WORX is a momentum vehicle, not a sleepy swing.

More Breaking News

• Frontline (FRO) Stock Draws Fresh Bullish Target From BTIG
• BTBT Stock Drifts Lower As Charts Flag Key Support
• AIXI Stock Volatility Spikes As Traders Target AI Micro-Cap
• ACHR Stock Pulls Back As Traders Eye Heavy Cash Burn

Fundamentals show why longer‑term confidence is thin. SCWorx generated about $2.88M in revenue, but profitability is deeply negative, with profit margins around -140%. Return on equity is sharply negative, while cash of roughly $1.26M and a current ratio of 2.5 suggest short‑term bills are covered but not comfortably. With a price‑to‑sales ratio near 1.0 and price‑to‑book around 0.4, WORX screens “cheap,” yet the losses explain the discount.

Why Traders Are Closely Watching WORX Now

WORX is sitting at the crossroads where catalysts meet fear. On one hand, SCWorx just won approval for reinstatement of trading on the Nasdaq Capital Market effective 2026/10/07. That lifts a huge cloud. Listing on a senior exchange typically boosts visibility and liquidity, which many small‑cap traders chase.

On the other hand, the stock’s price action says confidence is shaky. WORX fell 17% in premarket trading, adding to an 11.2% drop from Friday’s close. That kind of back‑to‑back slide usually means early longs are bailing and shorts are leaning in. For nimble traders, it also means big intraday ranges and opportunity, but only if risk is tight.

The recent $938,000 private equity financing adds another layer. SCWorx sold 350,000 common shares plus five‑year warrants to institutions and accredited traders. That gives WORX cash for working capital and, more importantly, supports its push to satisfy Nasdaq requirements like a $1.00 minimum bid and more than 500,000 publicly held shares.

But the structure of the deal keeps everyone honest. The funds are locked in a segregated account and can be clawed back if the Nasdaq relisting and active trading aren’t fully in place by late 2026/10. That tells traders two things: the new backers demanded protection, and SCWorx management is under a clear deadline. Until WORX proves it can hold its Nasdaq slot and stabilize the bid, every spike is going to attract short‑term flippers and skeptics.

Conclusion

Right now, WORX is a classic Sykes‑style battleground stock. You have a beaten‑down chart, a fresh headline catalyst with the Nasdaq reinstatement, and a conditional cash raise designed to fix compliance problems. SCWorx has enough liquidity to keep the lights on, but the income statement shows real operating losses and heavy negative returns on capital. That combination is why longer‑term money is cautious while day traders swarm.

For active traders, WORX is all about discipline. The daily swings from $3 to $7 and back are proof that chasing without a plan is dangerous. The key is to respect the volatility, track the $1.00 Nasdaq bid threshold, and watch how volume reacts now that WORX is back on the Capital Market. If SCWorx can maintain compliance and calm the selling, sentiment may stabilize; if not, the financing clawback risk hangs over the story.

As Tim Sykes likes to say, “Volatility is opportunity for prepared traders, but a trap for those who don’t have rules.” WORX fits that perfectly. As Tim Bohen, lead trainer with StocksToTrade says, “The best way to learn is by tracking trades, wins, losses, and lessons learned. Every trade has something to teach.”. Treat SCWorx as a trading vehicle, study the chart, know the catalysts, and always, always cut losses fast. This analysis is for educational and research purposes only, and traders should do their own homework before making any decisions.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

• How to Read Stock Charts: A Guide for Beginners
• Trading Plan: 6 Steps to Create One
• How To Create a Stock Watchlist

Ready to build your watchlists? Check out these curated lists:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.